IL1B and cystic fibrosis: In well differentiated human airway epithelial cells (HAE) from cystic fibrosis (CF) and non-CF patients, combined treatment with IL-1β and TNFα led to a decrease in transmembrane potential and tight junctional barrier function, the changes appearing more rapidly in CF cells [37].